These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8823229)

  • 1. Factors often not considered before a multicenter trial is started.
    Hardy E
    Clin Pharmacol Ther; 1996 Aug; 60(2):121-3. PubMed ID: 8823229
    [No Abstract]   [Full Text] [Related]  

  • 2. An introduction to research for primary dental care clinicians part 3: stage 5. Writing a protocol.
    Eaton KA; Santini A
    Prim Dent Care; 2011 Apr; 18(2):91-4. PubMed ID: 21457629
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials. Ventilator study gets second wind.
    Malakoff D
    Science; 2003 Jul; 301(5630):149. PubMed ID: 12855776
    [No Abstract]   [Full Text] [Related]  

  • 4. [Information provided in writing for "informed consent" in clinical trials].
    Sella A
    Harefuah; 1999 May; 136(9):669-72, 756. PubMed ID: 10955084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to design a clinical trial.
    Curtis BM; Barrett BJ; Parfrey PS
    Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789
    [No Abstract]   [Full Text] [Related]  

  • 6. Co-bedding twins: how pilot study findings guided improvements in planning a larger multicenter trial.
    Hayward K; Campbell-Yeo M; Price S; Morrison D; Whyte R; Cake H; Vine J
    Nurs Res; 2007; 56(2):137-43. PubMed ID: 17356445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in standards of research compensation and child assent practices: a comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials.
    Kimberly MB; Hoehn KS; Feudtner C; Nelson RM; Schreiner M
    Pediatrics; 2006 May; 117(5):1706-11. PubMed ID: 16651328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing accrual in cooperative group clinical trials.
    Demmy TL; Yasko JM; Collyar DE; Katz ML; Krasnov CL; Borwhat MJ; Battershell A; George SL
    J Clin Oncol; 2004 Aug; 22(15):2997-3002. PubMed ID: 15284251
    [No Abstract]   [Full Text] [Related]  

  • 9. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B
    IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract]   [Full Text] [Related]  

  • 10. Numerous violations of federal informed consent requirements.
    Maloney DM
    Hum Res Rep; 2004 Jan; 19(1):1-3. PubMed ID: 14997901
    [No Abstract]   [Full Text] [Related]  

  • 11. An index for assessing blindness in a multi-centre clinical trial: disulfiram for alcohol cessation--a VA cooperative study.
    James KE; Bloch DA; Lee KK; Kraemer HC; Fuller RK
    Stat Med; 1996 Jul; 15(13):1421-34. PubMed ID: 8841652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing the informed consent process in large multicenter projects.
    Mark BA; Geddes N; Salyer J; Smith CS
    Nurs Res; 1999; 48(2):114-7. PubMed ID: 10190839
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of a writing improvement intervention program on the readability of the research informed consent document.
    Philipson SJ; Doyle MA; Nightingale C; Bow L; Mather J; Philipson EH
    J Investig Med; 1999 Nov; 47(9):468-76. PubMed ID: 10572377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of subjects for clinical trials after informed consent: does gender and educational status make a difference?
    Gitanjali B; Raveendran R; Pandian DG; Sujindra S
    J Postgrad Med; 2003; 49(2):109-13. PubMed ID: 12867683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Informed consent: practices and views of investigators in a multinational clinical trial.
    Sabik L; Pace CA; Forster-Gertner HP; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Killen J; Emanuel EJ; Grady C
    IRB; 2005; 27(5):13-8. PubMed ID: 16425476
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing the quality of randomized controlled trials: quality of design is not the only relevant variable.
    Berk PD; Sacks HS
    Hepatology; 1999 Nov; 30(5):1332-4. PubMed ID: 10534359
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in institutional review board responses to a standard, observational, pediatric research protocol.
    Mansbach J; Acholonu U; Clark S; Camargo CA
    Acad Emerg Med; 2007 Apr; 14(4):377-80. PubMed ID: 17312334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New regulation for multicenter clinical trials and its repercussions on the function of current clinical trial ethics committees].
    García Herrera JL
    Rev Esp Quimioter; 2003 Dec; 16(4):383-4. PubMed ID: 14961130
    [No Abstract]   [Full Text] [Related]  

  • 20. Sample size calculation for multicenter randomized trial: taking the center effect into account.
    Vierron E; Giraudeau B
    Contemp Clin Trials; 2007 Jul; 28(4):451-8. PubMed ID: 17188941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.